MedTrace Logo

Phenolic-rich Oats and Artery Improvement

NCT02731755 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2019-11-01

Study results available
· View outcomes & findings →

Summary

In this proposed human trial, the investigators aim to establish whether consumption of one portion of phenolic acid-rich oats leads to acute improvements (i.e. 1-24h post-intake) in markers of cardiovascular disease risk relative to an energy matched control intervention in healthy men with high-normal to mildly elevated blood pressure.

Conditions

  • Healthy

Interventions

OTHER

Oat

The study oat intervention products will consist of 67.7g oatflake and 22.5g oatbran concentrate.

OTHER

Control

60g cream of rice

Sponsors & Collaborators

  • Biotechnology and Biological Sciences Research Council

    collaborator OTHER

  • Rothamsted Research

    collaborator UNKNOWN

  • PepsiCo Global R&D

    collaborator INDUSTRY

  • University of Roehampton

    collaborator OTHER

  • University of Reading

    lead OTHER

Principal Investigators

  • Jeremy P Spencer, Professor · University of Reading

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02731755 on ClinicalTrials.gov